Key result
Intravenous immunoglobulin administration led to a dramatic decrease in troponin levels, resolution of chest pain, and normalization of ECG findings in a patient with perimyocarditis.
Why the study?
Does intravenous immunoglobulin improve clinical and biochemical outcomes in a pediatric patient with perimyocarditis mimicking acute coronary syndrome?
Case Report (n=1)
No
Does intravenous immunoglobulin improve clinical and biochemical outcomes in a pediatric patient with perimyocarditis mimicking acute coronary syndrome?
Intravenous immunoglobulin administration resulted in dramatic clinical and biochemical improvement in a pediatric patient with perimyocarditis mimicking acute coronary syndrome.
May suggest IVIG benefit in pediatric perimyocarditis; hypothesis-generating and requires prospective trials before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Alkan et al. (2016) conducted a case report in Perimyocarditis (n=1). Intravenous immunoglobulin was evaluated. Intravenous immunoglobulin administration led to a dramatic decrease in troponin levels, resolution of chest pain, and normalization of ECG findings in a patient with perimyocarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: